Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis

Accepted/In Press date: 27 September 2020

e-pub ahead of print date: 17 October 2020

Additional Information: Funding Information: Prof. Dittmann has received compensation for serving as consultant or speaker, or he or the institution he works for have received research support or royalties from the organizations or companies indicated: EU (FP7 Programme), US National Institute of Mental Health (NIMH), German Federal Ministry of Health/Regulatory Agency (BMG/BfArM), German Federal Ministry of Education and Research (BMBF), German Research Foundation (DFG), Volkswagen Foundation; Boehringer Ingelheim, Ferring, Janssen-Cilag, Lilly, Lundbeck, Otsuka, Servier, Shire, Sunovion/Takeda and Theravance. He owns Eli Lilly stock. Funding Information: Dr. Elizabeth Liddle has had grant support from the Wellcome Trust. Funding Information: Prof. Sonuga-Barke’s financial declarations are: Speaker fees, and conference support from Shire Pharma. Consultancy from Neurotech solutions, Copenhagen University and Berhanderling, Skolerne, KU Leuven. Book royalties from OUP and Jessica Kingsley. Financial support received from Arrhus Univeristy and Ghent University for visiting Professorships. Grants awarded from MRC, ESRC, Wellcome Trust, European Union, NIHR, Nuffield Foundation, Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO), MQ – Transforming Mental health, The Waterloo Foundation. Editor-in-Chief JCPP – supported by a buy-out of time to Kings College London and personal Honorarium. Non-financial declarations are: Member of the European ADHD Guidelines Group Funding Information: Prof. Ian Wong reports grants from European Union FP7 programme and Hong Kong Research Gran Council during the conduct of the study; grants from Shire, grants from Janssen-Cilag, grants from Eli-Lily, grants from Pfizer, outside the submitted work; and Prof Wong was a member of the National Institute for Health and Clinical Excellence (NICE) ADHD Guideline Group and the British Association for Psychopharmacology ADHD guideline group and acted as an advisor to Shire. Funding Information: The research leading to these results received support from the European Community’s Seventh Framework Programme ( FP7/2007-2013 ) under grant agreement numbers 260576 (ADDUCE). Publisher Copyright: © 2020

Keywords: Attention deficit/hyperactivity disorder (ADHD), growth, height, methylphenidate, puberty, stimulants, weight

Local EPrints ID: 444975

URI: http://eprints.soton.ac.uk/id/eprint/444975

DOI: doi:10.1016/j.neubiorev.2020.09.031

ISSN: 0149-7634

PURE UUID: e7daa6a3-f346-42cd-8d2d-5a7366d6d1ca

ORCID for Hanna Kovshoff: orcid.org/0000-0001-6041-0376

Date deposited: 13 Nov 2020 17:33

Last modified: 17 Mar 2024 06:03